Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Revenue and Financial Performance
EW logo

Edwards Lifesciences Sales Surge 16.7% to $1.6 Billion Driven by Heart Valve Innovation

EW10-QFiling Date: 5/6/2026
Edwards Lifesciences Corporation
Description

What this story covers

Edwards Lifesciences reported strong Q1 2026 results, with sales hitting $1.65 billion. Growth was led by a 52% surge in mitral and tricuspid therapies, though the company faces significant ongoing IRS tax disputes and rising manufacturing costs.

Story snapshot

CompanyEdwards Lifesciences Corporation
TickerEW
VariantStandard detailed
Duration12:45
Filing type10-Q
PeriodQ4 2026
IndustryHealthcare & Pharmaceuticals
Accession0001099800-26-000026
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in